55I LLC’s Colgate-Palmolive CL Stock Holding History

55I LLC’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$465K	Buy	6,614 +3,665	+124%	+$287K	0.01%	400
2022 Q2	$236K	Buy	+2,949	New	+$231K	0.01%	491

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

55I LLC's CL Position: Q3 2022 in Review

55I LLC increased its Colgate-Palmolive (CL) stake by 124% in Q3 2022, buying an estimated $287K and bringing the position to 6,614 shares worth $465K. The position accounts for 0.01% of the portfolio, ranked #400.

55I LLC first reported a position in CL in Q2 2022 and has held it in 2 quarters since. 1,614 funds tracked by Wall St. Rank hold CL as of Q3 2022.

55I LLC held 6,614 shares of Colgate-Palmolive worth $465K as of Q3 2022.
55I LLC bought 3,665 Colgate-Palmolive shares in Q3 2022, an estimated $287K.
Colgate-Palmolive made up 0.01% of 55I LLC's portfolio in Q3 2022, its #400 holding.
55I LLC first reported a position in Colgate-Palmolive in Q2 2022 and has held it in 2 quarters since.
1,614 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2022.

Based on 55I LLC's 13F filing for Q3 2022, filed 14 Nov 2022.